(PharmaNewsWire.Com, May 10, 2019 ) Chronic diseases, including heart disease, stroke, diabetes, and obesity, are the leading causes of death in the world and account for most of the nation’s health care costs. According to report of CDC, in 2018, approximately more than 9% of the population has diabetes, which is the leading cause of kidney failure, lower-limb amputations in US.
Moreover, the data also suggests that 1.5 million Americans are diagnosed with diabetes every year in the US. Similar trends for high presence of diabetes are prevalent around other geographies of the globe that include Asia Pacific, Europe, Middle East and Africa. For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation in 2017, south-east Asia is home to approximately one-fifth (19%) of the total diabetes population worldwide.
Koninklijke Philips N.V. GE Healthcare Boston Scientific Corporation Omron Healthcare Medtronic Plc. Welch Allyn Resideo Technologies (Honeywell Life Care) Abbott Laboratories Biotronik SE & Co. KG Masimo Corporation Market Segmentation
Product Insights
The global remote patient monitoring devices market, based on product is segmented vital sign monitors and special monitors. In 2018, the special monitors segment held the largest share of the market, by product.
This segment is also expected to dominate the market in 2027 owing to increasing technological advancements. Moreover, the special remote patient monitoring segment is anticipated to witness the significant growth rate of 9.1% during the forecast period, 2019 to 2027 owing to rising investments in patient monitoring devices segments from medical devices companies.
Application Insights
Global remote patient monitoring devices market, based on the application was segmented into cardiovascular diseases treatment, cancer treatment, sleep disorder treatment, diabetes treatment and weight management & fitness monitoring. In 2018, the cardiovascular diseases treatment segment held the largest share of the market, by application.
In addition, the segment is also expected to grow at the fastest rate during the coming years owing to increasing number of the cardiovascular surgeries, increasing number of patients suffering from diseases such as cardiovascular disease, cardiac arrest and cardiac hypertension as they need regular blood pressure monitoring due to frequent fluctuations.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: